Evidence map›Paper›PMID 36819722›Full record

ArticleFrontiers in aging neuroscience2023

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II.

Tao Ma, Raymond Chuen-Chung Chang, Shannon L Macauley

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tao MaDepartment of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Raymond Chuen-Chung ChangLaboratory of Neurodegenerative Diseases, LKS Faculty of Medicine, School of Biomedical Science, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
Shannon L MacauleyDepartment of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States.

Funding

Wake Forest University School of Medicine Alzheimer's Disease Research CenterP30AG072947 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · 2021 to 2026
$24.3M
The metabolic interplay of sleep and Alzheimer's diseaseR01AG068330 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MACAULEY-RAMBACH, SHANNON L · 2020 to 2024
$3.5M
Isoform-specific roles of AMPK in synaptic failure and memory deficit in Alzheimer's DiseaseR01AG055581 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MA, TAO · 2017 to 2021
$2.9M
Role of protein synthesis in Alzheimers disease-associated impairments of synaptic plasticity and memoryR01AG056622 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MA, TAO · 2017 to 2021
$2.4M
Targeting protein synthesis dysregulation in Down syndrome-associated cognitive impairment with agingR01AG073823 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Tao Ma · 2021 to 2026
$2.3M
NIA NIH HHS P30 AG072947NIA NIH HHS R01 AG055581NIA NIH HHS R01 AG056622NIA NIH HHS R01 AG068330NIA NIH HHS R01 AG073823
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

agingAlzheimer's diseasebiomarkerbrain imagingcognitive impairmentMCImetabolism

Identifiers

PMID36819722
PMCPMC9936185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.